Wikisage, the free encyclopedia of the second generation, is digital heritage
Riluzole: Difference between revisions
Jump to navigation
Jump to search
(Created page with "Rhone Poulenc medicament marketed as natrium channel blocking agent") |
No edit summary |
||
| Line 1: | Line 1: | ||
Rhone Poulenc medicament marketed as natrium channel blocking agent | Rhone Poulenc medicament marketed as natrium channel blocking agent with a modesto benefit on ALS. | ||
Revision as of 15:35, 29 October 2018
Rhone Poulenc medicament marketed as natrium channel blocking agent with a modesto benefit on ALS.